The decision to conduct a head-to-head comparative trial: A game-theoretic analysis

Medical Decision Making

Volumn 27, Issue 4, 2007, Pages 364-379

  Mansley, Edward C ^a   Elbasha, Elamin H ^a   Teutsch, Steven M ^a   Berger, Marc L ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Clinical trials; Comparative effectiveness; Comparative trials; Drug comparisons; Economic incentives; Health economics; Pharmaceutical decisions; Pharmacoeconomics

Indexed keywords

ARTICLE; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; HEALTH CARE COST; MEDICAL DECISION MAKING; METHODOLOGY; OUTCOME ASSESSMENT; PRESCRIPTION; PROBABILITY; PROFIT; RISK ASSESSMENT; STATISTICAL DISTRIBUTION; THEORETICAL MODEL; THEORETICAL STUDY;

CLINICAL TRIALS; DECISION MAKING; DRUG INDUSTRY; ECONOMICS, PHARMACEUTICAL; GAME THEORY; HEALTH SERVICES RESEARCH; HUMANS; MARKETING; MEDICARE; UNITED STATES; UNITED STATES AGENCY FOR HEALTHCARE RESEARCH AND QUALITY;

EID: 34547103006     PISSN: 0272989X     EISSN: 1552681X     Source Type: Journal    
DOI: 10.1177/0272989X07303825     Document Type: Article

References (14)

1. NewsEdge Corporation. Comparable alternatives, cost effectiveness, and clinical trial data. 2 June 2004.
2. Medicare Prescription Drug, Improvement, and Modernization Act of 2003 Available from: URL: http://www.cms.hhs.gov/medicarereform/MMAactFullText.pdf. Accessed 24 August 2005.
3. Tunis SR, Stryer DB, Clancy CM Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA. 2003 ; 290 (12). 1624 - 32.
4. Claxton K., Cohen JT, Neumann PJ When is evidence sufficient? A framework for making use of all available information in medical decision making and for deciding whether more is needed. Health Aff. 2005 ; 24 (1). 93 - 101.
5. DiMasi JA, Hansen RW, Grabowski HG The price of innovation: new estimates of drug development costs. J Health Econ. 2003 ; 22: 151 - 85.
6. von Neumann J., Morgenstern O. Theory of Games and Economic Behavior. Princeton (NJ): Princeton University Press; 1944.
7. Dixit AK, Nalebuff BJ Thinking Strategically: The Competitive Edge in Business, Politics, and Everyday Life New York: W.W. Norton & Company ; 1991.
8. Fundenberg D., Tirole J. Game Theory Cambridge (MA): MIT Press; 1991.
9. Nash J. The bargaining problem. Econometrica. 1950 ; 18: 155 - 62.
10. Nash J. Equilibrium points in n-person games. Proc Natl Acad Sci U S A. 1950 ; 36: 48 - 9.
11. Nicholson W. Microeconomic Theory: Basic Principles and Extensions. 4 th ed. Chicago: Dryden Press ; 1989.
12. Rosen CJ, Hochberg MC, Bonnick SL, Treatment with once-weekly alendronate 70 mg compared with once-weekly risedronate 35 mg in women with postmenopausal osteoporosis: A randomized double-blind study. J Bone Min Res. 2005 ; 20 (1). 141-51.
13. Rosen CJ, Hochberg MC, Bonnick SL, et al. Treatment with once-weekly alendronate 70 mg compared with once-weekly risedronate 35 mg in women with postmenopausal osteoporosis: a randomized double-blind study. J Bone Min Res. 2005 ; 20 (1). 141 - 51. 13. Helfand M., Carson S., Kelley C. Drug class review on HMG-CoA reductase inhibitors (statins). Final report, 2005. Available from: URL: http://www.ohsu.edu/drugeffectiveness/reports/documents/ Statins%20Final%20Report%20u3.pdf. Accessed 31 July 2006.
14. Centers for Medicare and Medicaid Services. Guidance for National Coverage Determination with Data Collection as a Condition of Coverage: Coverage with Evidence Development. Guidance for the Public, Industry, and CMS Staff. Document issued 12 July 2006.